Racemization of the gastrointestinal antisecretory chiral drug esomeprazole magnesium via the pyramidal inversion mechanism: A theoretical study
Authors:
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Insights into the future of gastric acid suppressionNature Reviews Gastroenterology & Hepatology, 2009
- Stereoselective Disposition of Proton??Pump InhibitorsClinical Drug Investigation, 2008
- Omeprazole2007
- The Development of a New Proton‐Pump Inhibitor: The Case History of Pantoprazole2006
- Esomeprazole in the Framework of Proton‐Pump Inhibitor Development2006
- Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretionAlimentary Pharmacology & Therapeutics, 2003
- A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazoleNature Reviews Drug Discovery, 2003
- Putting chirality to work: the strategy of chiral switchesNature Reviews Drug Discovery, 2002
- Stereochemical assignment of the enantiomers of omeprazole from X-ray analysis of a fenchyloxymethyl derivative of (+)-(R)-omeprazoleTetrahedron: Asymmetry, 1997
- Omeprazole: The first proton pump inhibitorMedicinal Research Reviews, 1990